Paysign (PAYS)
Runs prepaid payment programs for plasma centers, drugmakers, and healthcare clients.
$12.37
vs last close−0.54 (−4.18%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 53.67% | 30.30M shares | |
|---|---|---|---|
| 140 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 35.01% | 19.77M shares | |
| 13 holders · as of Sep 17, 2026 | |||
| Other | ≈ 11.32% | 6.39M shares | |
| remainder | |||
56.46M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
140 holders · 30.30M shares · 40 new positions · 98 increased · 25 reduced · 16 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Topline Capital Management, LLC | 4.64M | 8.22% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 3.08M | 5.45% | +727.6K | Aug 7, 2026 |
| Punch & Associates Investment Management, Inc. | 2.07M | 3.67% | +15.4K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.60M | 2.83% | +111.4K | Aug 13, 2026 |
| Thompson Siegel & Walmsley LLC | 1.41M | 2.50% | −253.1K | Aug 11, 2026 |
| Renaissance Technologies LLC | 1.07M | 1.90% | −457.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 1.05M | 1.85% | +217.6K | Aug 12, 2026 |
| Palisades Investment Partners, LLC | 1.00M | 1.77% | +6.9K | Aug 4, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Topline Capital Management, LLC | 9.90% | 5.34M | 13G | Feb 10, 2025 |
| BlackRock, Inc. | 5.40% | 3.03M | 13G | Jul 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 16, 2026 | Joan M. Hermandirector, officer: EVP, Operations | Sale | 38,900 | $11.74 | 609,421 |
| Sep 15, 2026 | Joan M. Hermandirector, officer: EVP, Operations | Sale | 21,004 | $12.38 | 648,321 |
| Sep 9, 2026 | Michael C. Ngoofficer: Chief Innovation Officer | Sale | 79,925 | $12.74 | 2,350,000 |
| Sep 8, 2026 | Michael C. Ngoofficer: Chief Innovation Officer | Sale | 70,075 | $12.85 | 2,429,925 |
| Feb 3, 2026 | Matthew Baker Turnerofficer: PRES., PATIENT AFFORDABILITY | Sale | 15,057 | $4.16 | 454,943 |
| Jun 1, 2026 | Bradley Kramer Cunninghamofficer: Chief Technology Officer | Sale | 3,000 | $7.80 | 348,631 |
| May 29, 2026 | Bradley Kramer Cunninghamofficer: Chief Technology Officer | Sale | 10,000 | $7.30 | 351,631 |
| Aug 12, 2026 | Jeffery Bradford Bakerofficer: Chief Financial Officer | Sale | 35,000 | $12.62 | 542,171 |
| Aug 6, 2026 | Mark Newcomerdirector, 10 percent owner, officer: CEO | Sale | 150,000 | $11.88 | 9,163,002 |
| Jul 29, 2026 | Mark Newcomerdirector, 10 percent owner, officer: CEO | Sale | 50,000 | $9.38 | 9,222,027 |
House and Senate disclosures
Not reported.